FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Artificial Vital Organ And Medical Bionics Market Overview:

According to FutureWise analysis the market for artificial vital organ and medical bionics in 2023 is US$ 30.35 billion, and is expected to reach US$ 62.81 billion by 2031 at a CAGR of 9.52%.

The Artificial Vital Organs and Medical Bionics market is projected to be hampered by criticism surrounding artificial organ transplantation. There are several ethical and physiological factors to consider before deciding on artificial organ implantation. The ethical aspect in the United States refers to clinicians adhering to the Nuremberg Code, which contains laws created by the Department of Health and Human Services to protect human subjects during experimental research and trials. The physiological aspect includes a patient's inability to make an informed decision about whether or not to have a heart transplant.

An artificial organ is a man-made device that can be implanted or integrated into a patient in order to replace a sick organ and restore its specific function. Medical bionics is the study of how mechanics and electronics can be used to replace a mechanically powered limb or other part of a functional organ.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Artificial Vital Organ And Medical Bionics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Artificial Vital Organ And Medical Bionics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Artificial Vital Organ And Medical Bionics Market:

Abiomed Inc.
Touch Bionics Inc.
F. Hoffmann-La Roche AG
Baxter Inc
Medtronic Plc.
MicroMed Cardiovascular, Inc.
Edwards Life Sciences Corporation
Frensenius Kabi.
Heartware International Inc
Ottobock Healthcare

(Note: The list of the major players will be updated with the latest market scenario and trends)

Artificial Vital Organ And Medical Bionics Market Segmentation:

By Product

Artificial vital organs market
- Artificial heart
- Artificial kidney
- Artificial liver
- Artificial pancreas
- Artificial lungs
  - Oxygenators
  - Heart-Lung bypass machines
Medical bionics market
- Ear bionics (cochlear implants)
- Vision bionics
- Exoskeletons
- Bionic limbs
  - Bionic leg
  - Bionic hand
Brain bionics
- Spinal cord stimulators
- Deep brain stimulators
- Vagus nerve stimulators
Cardiac bionics
- Ventricular Assist Device (VAD)
  - Left Ventricular Assist Device (LVAD)
  - Right Ventricular Assist Device (RVAD)
- Heart valves
  - Mechanical heart valves
  - Biological tissue valves
  - Transcatheter heart valves

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Artificial Vital Organ And Medical Bionics Market By Product and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Artificial Vital Organ And Medical Bionics Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Artificial Vital Organ And Medical Bionics Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Artificial Vital Organ And Medical Bionics Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Artificial Vital Organ And Medical Bionics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Artificial vital organs market
  1.1. Artificial heart
  1.2. Artificial kidney
  1.3. Artificial liver
  1.4. Artificial pancreas
  1.5. Artificial lungs
  1.5.1. Oxygenators
  1.5.2. Heart-Lung bypass machines
  2. Medical bionics market
  2.1. Ear bionics (cochlear implants)
  2.2. Vision bionics
  2.3. Exoskeletons
  2.4. Bionic limbs
  2.4.1. Bionic leg
  2.4.2. Bionic hand
  3. Brain bionics
  3.1. Spinal cord stimulators
  3.2. Deep brain stimulators
  3.3. Vagus nerve stimulators
  4. Cardiac bionics
  4.1. Ventricular Assist Device (VAD)
  4.1.1. Left Ventricular Assist Device (LVAD)
  4.1.2. Right Ventricular Assist Device (RVAD)
  4.2. Heart valves
  4.2.1. Mechanical heart valves
  4.2.2. Biological tissue valves
  4.2.3. Transcatheter heart valves
8. North America Artificial Vital Organ And Medical Bionics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
9. Latin America Artificial Vital Organ And Medical Bionics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
10. Europe Artificial Vital Organ And Medical Bionics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.7. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
11. Asia Pacific Artificial Vital Organ And Medical Bionics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
12. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
13. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Abiomed Inc.
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Touch Bionics Inc.
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. F. Hoffmann-La Roche AG
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Baxter Inc
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Medtronic Plc.
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. MicroMed Cardiovascular, Inc.
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Edwards Life Sciences Corporation
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Frensenius Kabi.
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Heartware International Inc
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Ottobock Healthcare
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
15. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by
  administrations
  5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients